CS logo
small CS logo
MSD Norge A/S

Drammen, Norway
Pharmaceutical company in Oslo
Haakon VIIs gate 5, 0161 Oslo

About MSD Norge A/S


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
1
Organon and Co
1
Total Rows: 2

Clinical Trials at MSD Norge A/S


During the past decade, MSD Norge A/S conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200Started TrialsCompleted Trails20150123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
2015-12-01
2016-10-06
Terminated
2,016
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
2015-12-18
2026-10-02
Recruiting
1,609

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsMerck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Organon and Co: 1Organon and Co: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at MSD Norge A/S


According to Clinical.Site data, the most researched conditions in "MSD Norge A/S" are "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Anal Cancer" (1 trials), "Anal Carcinoma" (1 trials) and "Bile Duct Cancer" (1 trials). Many other conditions were trialed in "MSD Norge A/S" in a lesser frequency.

Clinical Trials Intervention Types at MSD Norge A/S


Most popular intervention types in "MSD Norge A/S" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "ENG-E2 125 μg/300 μg vaginal ring" (1 trials), "LNG-EE 150 μg/30 μg COC" (1 trials) and "pembrolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MSD Norge A/S


The vast majority of trials in "MSD Norge A/S" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at MSD Norge A/S


Currently, there are NaN active trials in "MSD Norge A/S". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MSD Norge A/S, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MSD Norge A/S, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 1Recruiting: 1Terminated: 1Terminated: 1